Dicerna pharmaceuticals tender
WebDec 25, 2024 · LEXINGTON, Mass.--(BUSINESS WIRE)-- Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Novo Nordisk’s cash tender offer for Dicerna expired at 11:59 p.m., Eastern Time, on December 24, … WebNov 18, 2024 · Novo Nordisk to acquire Dicerna Pharmaceuticals including the RNAi research technology platform. Bagsværd, Denmark, 18 November 2024 – Novo Nordisk …
Dicerna pharmaceuticals tender
Did you know?
WebDicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary … WebNov 18, 2024 · The acquisition is a rare deal for the Danish drugmaker, which has been partnered with Dicerna since 2024. Diabetes drug specialist Novo Nordisk has agreed to acquire Dicerna Pharmaceuticals in a deal worth $3.3 billion, a strategic bet that an existing wide-ranging alliance between the two will yield multiple medicines for a range of …
WebNov 18, 2024 · Upon the successful completion of the tender offer, Novo Nordisk’s acquisition subsidiary will be merged into Dicerna, and any remaining shares of common … WebDec 28, 2024 · LEXINGTON, Mass.--(BUSINESS WIRE)-- Novo Nordisk today announced that the acquisition of Dicerna Pharmaceuticals, Inc. (Dicerna; Nasdaq: DRNA), …
WebDec 25, 2024 · Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as …
WebDec 27, 2024 · -- Novo Nordisk on Thursday reached a definitive agreement to acquire Dicerna Pharmaceuticals with a cash tender offer of $38.25 per share, for a total value of around $3.3 billion. The closing of... April 11, 2024
WebDec 26, 2024 · Unless the tender offer is extended, the offer and withdrawal rights will expire on December 27, 2024. On November 18, 2024, Dicerna agreed to be acquired by Novo Nordisk A/S (NVO) for $38.25 per ... how many people live near the coastWebDec 27, 2024 · Novo Nordisk has filed a Tender Offer Statement on Schedule TO with the SEC containing an offer to purchase all of the outstanding shares of Dicerna common … how can we help stop bullyingWebDec 25, 2024 · dicerna’s stockholders and other investors are urged to read the tender offer materials (including an offer to purchase, a related letter of transmittal and certain … how can we help stop animal testingWebNov 19, 2024 · Per the agreement, Novo Nordisk will begin a cash tender offer to acquire all outstanding shares of Dicerna’s common stock for $38.25 per share in cash. The … how can we help slow down global warmingWebNovo Nordisk has been advised by the depositary for the tender offer that a total of approximately 64,946,526 shares of Dicerna s common stock were validly tendered and not validly withdrawn in the tender offer as of the tender offer expiration at 5.00 pm EST on 27 December 2024 , which represent approximately 82.6% of the total number of ... how can we help someone with ptsdWebThis Dicerna Pharmaceuticals, Inc. Third Amended and Restated 2007 Employee, Director and Consultant Stock Plan was duly adopted by the Board of Directors and stockholders of Dicerna Pharmaceuticals, Inc. (the “Company”) on July 8, 2008, and amends, restates and supersedes in its entirety the Dicerna Pharmaceuticals, Inc. how can we help stop gender inequalityWebNovo Nordisk announces completion of Dicerna Pharmaceuticals acquisition. Bagsværd, Denmark, 28 December 2024 – Novo Nordisk today announced that the acquisition of … how many people live new york city